Cyclometallated (Azobenzene)palladium(II) Complex
tem. Other procedures were as described previously.[11] 1,4,7-Trithi-
acyclononane was obtained from Aldrich and used as supplied.
study in CD2Cl2 showed that the azobenzene multiplets were most
resolved at 263 K, while the SCH2 resonances sharpened to υ1/2
≈
The compounds [(HMB)RuII{η3-tpdt}] (3), [(Cp*)RuIII{η3-tpdt}] 30 Hz at δ = 3.41 and 2.78 ppm, respectively, at 263 K. These sig-
(4) and [{Pd(C6H4N=NC6H5)(µ-Cl)}2] (5) were prepared as pre-
nals resolved into overlapping doublets at δ = 3.29 and 2.73 ppm,
respectively, at 193 K. ESI+ MS: m/z 467 [M+]. ESI– MS: m/z 358
[M–], with higher mass “clusters” at m/z 665 and 972. MALDI-
TOF MS+: m/z 467 [M]+. MALDI-TOF MS–: m/z 359 [M–]. IR
viously reported.[8,9,15]
4.2. Reaction of [Pd(C6H4N=NC6H5)(µ-Cl)]2 (5)
(i) With AgPF6, Followed by 1,4,7-Trithiacyclononane (9S3): Solid
AgPF6 (86 mg, 0.34 mmol) was added, with stirring, to a suspen-
sion of 5 (100 mg, 0.15 mmol) in acetone (15 mL). Precipitation of
white AgCl occurred almost immediately as the solution gradually
changed from red to orange-yellow. After 1 h the solution was fil-
tered and 9S3 (56 mg, 0.31 mmol) was added to the filtrate. An
instantaneous colour change to deep red was observed. This mix-
ture was stirred for 1 h and then filtered to remove some insoluble
black solids. The dark red filtrate was evaporated to dryness and
the residue extracted with MeCN (10 mL) and filtered again. Ad-
dition of diethyl ether to the filtrate, followed by cooling at –30 °C
for 24 h, led to the formation of red orthorhombic crystals of
[(9S3)Pd(C6H4N=NC6H5)]PF6 (6A; 151 mg, 80%). Concentration
of the mother liquor and addition of diethyl ether gave a second
crop of 6A (25 mg, 13%) after 2 days at –30 °C. Diffraction-quality
crystals were obtained by the slow diffusion of diethyl ether into a
concentrated solution of complex 6A in acetone at –10 °C after
three days.
(KBr): ν = 3047 (w), 2976 (m), 2959 (w), 2909 (w), 1574 (s), 1551
˜
(w), 1481 (w), 1456 (w), 1445 (m), 1393 (s), 1316 (sh w), 1300 (m),
1258 (m), 1238 (m), 1217 (vw), 1200 (w), 1155 (w), 1109 (w), 1072
(w), 1040 (w), 1020 (w), 1001 (w), 891 (w), 829 (w), 814 (w), 764
(vs), 741 (m), 712 (w), 694 (s), 665 (w), 737 (vw), 611 (vw), 579
(vw), 550 (w), 523 (w), 494 (w), 440 (m) cm–1. C31H31Cl5N4Pd2S3
(945.92): calcd. C 39.4, H 3.3, N 5.9; found C 39.1, H 3.3, N 5.7.
(iii) With [(HMB)RuII{η3-tpdt}] (3): Complex
0.019 mmol) was added to stirred solution of
5
(12 mg,
a
3 (15 mg,
0.036 mmol) in methanol (10 mL). A gradual colour change from
red to brown occurred over 30 min. After stirring for 6 h, the solu-
tion was filtered to remove unreacted 5. NH4PF6 (20 mg,
0.12 mmol) was added and, after stirring for 15 min, the precipi-
tated brown solids were filtered. The brown product was then dis-
solved in MeCN (6 mL) and filtered to remove NH4Cl and the
excess NH4PF6. Addition of diethyl ether to the filtrate and subse-
quent cooling to –30 °C for 24 h gave brown needle-shaped crystals
of [{(HMB)RuII(µ-η2:η3-tpdt)}{Pd(C6H4N=NC6H5)}]PF6 (7;
26 mg, 85%).
Data for 6A: 1H NMR (300 MHz, CD3CN): δ = 8.18–8.15 (m, 1
H, Ph), 7.60 (unresolved m, 5 H, Ph), 7.47–7.31 (16-line m, 3 H,
Ph), 2.95–2.86 (8-line m, 6 H, SCH2), 3.08–2.98 (8-line m, 6 H,
SCH2) ppm. 13C NMR (300 MHz, CD3CN): δ = 165.1, 163.7,
154.3, 135.1, 133.9, 131.8, 131.7, 130.0, 127.6, 123.2 (all Ph),
33.9 ppm (SCH2). FAB+ MS: m/z 467 [M – PF6]+. FAB– MS: m/z
Data for 7: 1H NMR (400 MHz, CD3CN): δ = 8.00–7.99 (5-line m,
1 H, Ph), 7.76–7.74 (5-line m, 2 H, Ph), 7.63–7.61 (4-line m, 1 H,
Ph), 7.58–7.56 (5-line m, 3 H, Ph), 7.37–7.30 (11-line m, 2 H, Ph),
3.34–3.28 (6-line m, 1 H, SCH2), 3.13–3.06 (7-line m, 1 H, SCH2),
2.90–2.83 (5-line m, 1 H, SCH2), 2.71–2.65 (7-line m, 1 H, SCH2),
2.50–2.42 (8-line m, 1 H, SCH2), 2.27–2.15 (14-line m, 2 H, SCH2),
1.88–1.82 (8-line m, 1 H, SCH2), 2.11 (s, 18 H, C6Me6) ppm. 13C
NMR (400 MHz, CD3CN): δ = 166.0, 160.5, 152.3, 134.6, 133.6,
131.8, 131.4, 129.7, 127.4, 124.2 (all Ph), 101.6 (C6Me6), 45.5, 42.9,
34.0, 27.5 (all SCH2), 15.9 ppm (C6Me6). FAB+ MS: m/z 703 [M –
145 [PF ]–. IR (KBr): ν = 2960 (vw), 2936 (vw), 2860 (vw), 1635
˜
6
(w), 1485 (w), 1447 (w), 1432 (w), 1411 (w), 1394 (m), 1302 (w),
1239 (w), 1130 (vw), 1112 (vw), 1076 (vw), 1040 (vw), 869 (m), 839
[vs. (PF6)], 776 (s), 762 (m), 712 (m), 700 (m), 668 (vw), 557 [s
(PF6)], 375 (w) 354 cm–1. C18H21F6N2PPdS3 (612.96): calcd. C
35.3, H 3.5, N 4.6, S 15.7; found C 35.0, H 3.4, N 4.3, S 16.0.
PF6]+. FAB– MS: m/z 145 [PF ]–. IR (KBr): ν = 3040 (vw), 2956
˜
6
(ii) With 1,4,7-Trithiacyclononane (9S3): Dichloromethane (15 mL)
was added to a solid mixture of 5 (130 mg, 0.20 mmol) and 9S3
(72 mg, 0.40 mmol). A deep red solution was obtained almost im-
mediately. After stirring for 18 h, the solvent was removed in vacuo
and the product was extracted with MeOH (10 mL). The extracts
were filtered through a glass sinter (Por. 4) and the deep red filtrate
evacuated to dryness. The oily residue obtained was then recrystal-
lised from CHCl3 and hexane at room temperature to give
6B·CHCl3 as black needles (94 mg, 0.10 mmol, 100% based on 5)
after 3 days. Single crystals were obtained by layering a concen-
trated solution of this complex in non-dried chloroform with hex-
ane at room temperature. After 3 days, diffraction-quality black-
red needles of 6B·H2O and black needles of 6B·CHCl3 were ob-
tained. Another attempt to obtain single crystals from a solution
in MeCN/diethyl ether gave red crystals of 6B.
Data for 6B·CHCl3: 1H NMR (400 MHz, CDCl3 or 300 MHz,
CD2Cl2): δ = 8.12 (d, J = 7.2 Hz, 1 H, Ph), 7.85 (unresolved m, 4
H, Ph), 7.54 (unresolved m, 5 H, Ph), 7.43 (unresolved m, 3 H,
Ph), 7.32 (unresolved m, 2 H, Ph), 7.29–7.22 (unresolved m, 3 H,
Ph), 3.43 (br. s, υ1/2 = 70–100 Hz, 6 H, SCH2), 2.86 ppm (br. s,
υ1/2 = 70–100 Hz, 6 H, SCH2). These broad resonances shifted to
δ = 3.64 and 2.80 ppm, respectively, with a slight increase in CHCl3
content. A resonance at δ = 7.26 ppm (s, CHCl3) is clearly visible
in CD2Cl2 solution. 13C NMR (400 MHz, CDCl3): δ = 164.6,
133.9, 133.2, 131.6, 131.1, 130.2, 129.4, 127.9, 126.8, 125.2, 124.6,
122.6 (all Ph), 34.2 ppm (SCH2). A VT 1H NMR (298–193 K)
(vw), 2922 (w), 2853 (vw), 1459 (w), 1389 (m), 1304 (w), 1253 (w),
1236 (w), 1158 (vw), 1109 (w), 1072 (w), 1016 (w), 842 [vs. (PF6)],
772 (m), 712 (w), 693 (w), 558 [m (PF6)] cm–1.
C28H35F6N2PPdRuS3 (848.25): calcd. C 39.7, H 4.2, N 3.3, S 11.3;
found C 40.0, H 4.3, N 3.4, S 11.4.
(iv) With [Cp*RuIII{η3-tpdt}] (4): MeOH (10 mL) was added to a
mixture of 4 (20 mg, 0.051 mmol) and 5 (17 mg, 0.026 mmol). A
colour change from dark purple to dark brown was observed after
5 min. After stirring for 2 h, the solution was filtered through a
glass sinter (Por. 4) to remove some unreacted Pd complex 5.
NH4PF6 (25 mg, 0.15 mmol) was added to the dark brown filtrate
and, after stirring for 15 min, the reaction mixture was evacuated
to dryness. The residue was then extracted with MeCN (2ϫ3 mL)
and the extracts filtered through a Por. 4 glass sinter. Diethyl ether
was added to the filtrate to give a dark brown solid after 24 h at
–30 °C. This solid was further purified by recrystallization from
MeCN/diethyl ether to give [{Cp*RuIII(µ-η2:η3-tpdt)}2Pd](PF6)2
(8; 26 mg, 80%) as a black crystalline solid.
Data for 8: 1H NMR (300 MHz, CD3CN): δ = 3.03 (br. s, 8 H,
SCH2), 2.74–2.66 (6-line m, 8 H, SCH2), 1.77 ppm (s, 30 H,
C5Me5). FAB+ MS: m/z 1028 [M – PF6 + H]+, 883 [M – 2PF6 +
H]+, 827 [M – PF6 – 4CH2]+. FAB– MS: m/z 145 [PF6]–.
4.3. Reaction of [(9S3)Pd(C6H4N=NC6H5)]PF6 (6A)
(i) With 3: A mixture of 6A (23 mg, 0.038 mmol) and 3 (16 mg,
0.039 mmol) in MeOH (8 mL) was stirred for 1 h to give a brown
Eur. J. Inorg. Chem. 2009, 2282–2293
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjic.org
2291